• Dual Terminal Oxidase Inhibition by Pretomanid in TB Therapy

  2026-05-26

  The referenced study uncovers that pretomanid, a bicyclic nitroimidazole derivative, achieves potent bactericidal activity against Mycobacterium tuberculosis by simultaneously inhibiting both cytochrome bcc:aa3 and bd oxidase respiratory branches. This dual-target mechanism underpins new, highly effective drug regimens and highlights the value of rational drug combinations to limit resistance and improve tuberculosis therapy.

• ATG4B Nuclear Translocation Links Energy Deficiency to DNA R

  2026-05-25

  This study uncovers how energy deficiency drives ATG4B nuclear translocation, disrupting PRMT1-mediated DNA repair and promoting genomic instability in acute myeloid leukemia (AML). The findings delineate a mechanistic bridge between metabolic stress and leukemia progression, revealing ATG4B as a candidate target for restoring DNA repair in energy-compromised cancer cells.

• CHIR 99021 Trihydrochloride: Steering Organoid Fate for Tran

  2026-05-25

  This thought-leadership article unpacks how CHIR 99021 trihydrochloride—a potent, selective GSK-3 inhibitor—enables researchers to precisely modulate stem cell self-renewal and differentiation in advanced organoid systems. Integrating the newest mechanistic insights from human intestinal organoid research, it offers actionable guidance for translational scientists seeking to elevate their experimental workflows and move the frontier of regenerative medicine and metabolic disease research forward.

• Targeting Fructose Metabolism in Cancer: Mechanisms and Stra

  2026-05-24

  The reference study systematically reviews the role of fructose metabolism in cancer malignancy, highlighting upregulation of the polyol pathway and associated transporters as key drivers of tumor progression. By mapping these metabolic shifts, the paper underscores new therapeutic opportunities for targeting fructose utilization, with broad implications for translational cancer research.

• Calpain Inhibitor I, ALLN: Technical Guide for Assay Integra

  2026-05-23

  Calpain Inhibitor I, ALLN is a potent, selective inhibitor for calpain and cathepsin proteases, supporting apoptosis assay optimization and ischemia-reperfusion injury models. It should not be used for diagnostic or clinical applications, and best results depend on careful solution preparation and storage.

• 3X (DYKDDDDK) Peptide: Precision Epitope Tagging for Metal-S

  2026-05-22

  Explore the 3X (DYKDDDDK) Peptide as a hydrophilic epitope tag enabling precise, metal-dependent affinity purification and immunodetection of FLAG fusion proteins. This article reveals new insights into its metal-binding behavior, protocol nuances, and strategic value for structural biology and advanced ELISA workflows.

• Dantrolene Sodium Salt: Precision RyR Antagonist for DNA Rep

  2026-05-22

  Dantrolene sodium salt unlocks precise control of ryanodine receptor-mediated calcium release, enabling reliable modulation of DNA repair pathways in genome editing and disease models. This guide delivers actionable protocols, troubleshooting, and evidence-based tips to maximize experimental success using APExBIO's rigorously validated compound.

• Stattic in STAT3-Driven Disease: Beyond Oncology to Immune M

  2026-05-21

  Discover how Stattic, a leading STAT3 inhibitor, is unlocking new frontiers in both cancer research and immune-mediated skin disorders. This article uniquely explores the translational potential of STAT3 inhibition in psoriasis and HNSCC, highlighting mechanistic insights and advanced protocol guidance.

• Biotin-HPDP: Precision Thiol-Specific Protein Labeling Workf

  2026-05-21

  Biotin-HPDP (N-[6-(biotinamido)hexyl]-3’-(2’-pyridyldithio)propionamide) offers unmatched versatility for selective, reversible thiol protein biotinylation—enabling robust affinity purification, dynamic redox biology studies, and S-nitrosylation detection. Its medium-length spacer and cleavable disulfide linkage empower both sensitive capture and controlled release, making it a gold standard for complex proteomic workflows.

• Biotin-16-UTP: Practical Guide for RNA Labeling Workflows

  2026-05-20

  Biotin-16-UTP is a biotin-labeled uridine triphosphate analog for efficient in vitro RNA labeling, enabling sensitive RNA detection, purification, and interaction assays. It is best suited for workflows requiring streptavidin-based capture or visualization of RNA, but not for diagnostic or clinical use due to its research-grade specification.

• Elevating Low-Abundance Protein Detection in Translational R

  2026-05-20

  This thought-leadership article explores how hypersensitive HRP chemiluminescence has become a cornerstone for translational researchers striving to bridge basic mechanistic insight with real-world biomarker discovery. Drawing from emerging evidence—including minimally invasive molecular diagnostics in early atherosclerosis—this piece analyzes mechanistic, technical, and strategic factors that shape the future of immunoblotting detection. By contextualizing the APExBIO ECL Chemiluminescent Substrate Detection Kit (Hypersensitive) against the competitive landscape, the article delivers actionable guidance for experimental design and highlights new horizons for sensitive disease monitoring.

• MG-132 (Z-LLL-al): Applied Workflows for Apoptosis & Cell Cy

  2026-05-19

  MG-132 (Z-LLL-al) from APExBIO stands out as a precision tool for probing proteasome function, apoptosis, and cell cycle regulation across cancer and aging models. This guide translates recent mechanistic breakthroughs—including m6A/ubiquitination axis insights—into actionable experimental strategies, stepwise protocols, and troubleshooting solutions for reliable data in proteasome inhibition research.

• Erastin as a Precision Ferroptosis Inducer in Cancer Biology

  2026-05-19

  Erastin stands out as a validated ferroptosis inducer, offering targeted cell death induction in RAS/BRAF mutant cancer models. This guide details optimized workflows, troubleshooting insights, and new mechanistic advances to help researchers fully leverage Erastin in oxidative stress and cancer biology research.

• Anticancer Mechanisms of Paroxetine: Targeting MET and ERBB3

  2026-05-18

  This article examines the recent findings on paroxetine, a selective serotonin reuptake inhibitor, demonstrating its direct anticancer activity in human colorectal cancer cells through inhibition of the MET and ERBB3 kinases. The study highlights a novel drug repositioning approach, providing mechanistic insights and practical protocol considerations for translational oncology research.

• Applied Workflows with Amyloid Beta-Peptide (1-40) (human)

  2026-05-18

  Leverage Amyloid Beta-Peptide (1-40) (human) as a robust platform for modeling amyloid aggregation, neurotoxicity, and membrane interactions in Alzheimer's disease research. This guide details experimental enhancements, troubleshooting strategies, and protocol optimizations informed by the latest supercritical angle spectroscopy studies.

3470 records 13/232 page Previous Next First page 上5页 1112131415 下5页 Last page